Para a preparação EUDR, o código SH/NC 293790 está classificado como fora do âmbito.
Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10) O motor de âmbito indexado devolve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Porque é que esta página de referência dá essa resposta.
- Descrição do código
- Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
- Base no anexo I
- Sem entrada direta no anexo I
- Base da fonte
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Linhas ascendentes, descendentes e próximas.
A vista de biblioteca destina-se à navegação de referência. Use o verificador quando quiser executar outro código como ação.
29produtos químicos orgânicosnarrower2937hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof "incl. chain modified polypeptides", used primarily as hormonesout29379000hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)(2012-2500);hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives)(2002-2011)out293710pituitary "anterior" or similar hormones, and derivatives, used primarily as hormonesout293711somatropin, its derivatives and structural analogues, used primarily as hormonesout293712insulin and its salts, used primarily as hormonesout293719polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)out293721cortisone, hydrocortisone, prednisone "dehydrocortisone" and prednisolone "dehydrohydrocortisone"out293722halogenated derivatives of corticosteroidal hormonesout
O que isto significa para a preparação.
Esta linha não desencadeia diretamente a recolha de provas no resultado de âmbito atual.
Regulation (EU) 2023/1115 Annex I — relevant productsobtido em 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115obtido em 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)obtido em 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)obtido em 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8obtido em 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingobtido em 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersobtido em 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)obtido em 2026-08-08